Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $3.75 is 28.42% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 3.78||$ 4.50|
|Low:||$ 3.68||$ 2.92|
Company Description (as filed with the SEC)
· Brainstorm Cell Therapeutics Inc. is a leading biotechnology company committed to the development and commercialization of best-in-class autologous cellular therapies for the treatment of neurodegenerative diseases including: Amyotrophic Lateral Sclerosis ("ALS", also known as Lou Gehrig's disease); Progressive Multiple Sclerosis ("PMS"); and Parkinson's disease ("PD"). · NurOwn® leverages proprietary cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells (MSCs) to secrete high levels of neurotrophic factors (NTFs), modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival and improve neurological function. · Our wholly-owned Israeli subsidiary, Brainstorm Cell Therapeutics Ltd. ... More ...
Nasdaq Official Price
Nov. 15, 2019
Nov. 15, 2019